AURORA BIO

What this means for you

This application is over — abandoned 06 Jan 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88581740

Mark type

Design + words

Filed

16 Aug 2019

Abandoned

06 Jan 2021

Attorney of record

Heather Dunn

Goods and services

• Class 005 — Pharmaceuticals: Diagnostic agents, preparations and substances for medical purposes; diagnostic agents for medical purposes, namely, diagnostic scanning agents for in vivo use for detection and monitoring of systemic amyloid diseases, such as transthyretin amyloidosis, Light Chain Amyloidosis and LECT2 Amyloidosis; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the field of systemic amyloid disease; Radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; Pharmaceutical preparations for use in diagnosis and treatment of systemic amyloid disease; all of the aforesaid for human use

Owner

• AURORA BIO, INC., South San Francisco, CA, US
• Solex, LLC, Menlo Park, CA, US

Prosecution history

• 19 Jan 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 19 Jan 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 05 Jul 2020 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 05 Jul 2020 — FINAL REFUSAL E-MAILED
• 05 Jul 2020 — FINAL REFUSAL WRITTEN
• 11 Jun 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 11 Jun 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 09 Jun 2020 — NOTICE OF REVIVAL - E-MAILED
• 08 Jun 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 08 Jun 2020 — PETITION TO REVIVE-GRANTED
• 08 Jun 2020 — TEAS PETITION TO REVIVE RECEIVED
• 02 Jun 2020 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 02 Jun 2020 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 02 Jun 2020 — ASSIGNED TO LIE
• 29 May 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED